The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs
J Prev Alzheimers Dis
.
2020;7(4):288-290.
doi: 10.14283/jpad.2020.28.
Author
J Cummings
1
Affiliation
1
Jeffrey Cummings, MD, ScD, Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W Bonneville Avenue, Las Vegas, NV 89106, T: 702-701-7926, F: 702-722-6584, E: jcummings@cnsinnovations.com.
PMID:
32920632
DOI:
10.14283/jpad.2020.28
No abstract available
MeSH terms
Alzheimer Disease / drug therapy*
Disease Progression
Drug Development / economics
Drug Development / methods*
Humans
Prodromal Symptoms*
Randomized Controlled Trials as Topic